Pfizer Stock Has 29% Upside, Says a New Bull : comparemela.c

Guggenheim analysts initiated coverage of drug firm Pfizer at Buy with a $36 price target. Shares have lagged behind the market in recent years.

Related Keywords

, Emily Dattilo , Pfizer , Courtesy Pfizer , Vamil Divan , Dow Jones Market , Wall Street , Article Normal , Pharmaceuticals , Vaccines , Textiles , Wholesalers , Retail Wholesale , Healthcare Life Sciences , Clothing Textiles , Consumer Goods , Specialized Drugs Medications , Financial Performance , Earnings , Earnings Surprises , Analysts Amp 39 Comments Recommendations , Corporate Industrial News , Political General News , Respiratory Tract Diseases , Health , Immunizations , Medical Conditions , Novel Coronaviruses , Infectious Diseases , Medical Treatments Procedures , Content Types , Factiva Filters , C Amp Ampe Exclusion Filter , C Amp Ampe Industry News Filter , Synd , Street Notes , Biotech And Pharma , Healthcare , Moderna , Mrna , Pfe , S Amp Ampp 500 Index , Spx , Analysts Amp 39 Comments , Recommendations , Corporate , Industrial News , Political , General News , Medical Treatments , Procedures , Retail , Wholesale , Life Sciences , Clothing , Specialized Drugs , Medications ,